The utility and predictive value of combinations of low penetrance genes for screening and risk prediction of colorectal cancer

Human Genetics

Volumn 128, Issue 1, 2010, Pages 89-101

  Hawken, Steven J ^a,f   Greenwood, Celia M T ^b   Hudson, Thomas J ^d,g   Kustra, Rafal ^b   McLaughlin, John ^b,e,h   Yang, Quanhe ^c   Zanke, Brent W ^d,f   Little, Julian ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^d ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

^f OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h CANCER CARE ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; GENDER; GENETIC VARIABILITY; LOGISTIC REGRESSION ANALYSIS; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SIMULATION; COLORECTAL TUMOR; DNA FINGERPRINTING; EARLY DIAGNOSIS; EVALUATION; GENETIC SCREENING; GENETICS; HUMAN; PENETRANCE; PREDICTION AND FORECASTING; RISK; SENSITIVITY AND SPECIFICITY;

COLORECTAL NEOPLASMS; DNA FINGERPRINTING; EARLY DETECTION OF CANCER; GENETIC TESTING; HUMANS; PENETRANCE; PREDICTIVE VALUE OF TESTS; RISK; SENSITIVITY AND SPECIFICITY;

EID: 77954013977     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-010-0828-1     Document Type: Article

References (71)

1. Aaltonen L, Johns L, Järvinen H, Mecklin JP, Houlston R (2007) Explaining the familial colorectal cancer risk associated with mismatch repair (mmr)-deficient and mmr-stable tumors. Clin Cancer Res 13(1):356-361
2. Ahlbom A (1997) Cancer in twins: genetic and nongenetic familial risk factors. J Natl Cancer Inst 89:287-293
3. Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV (2007) Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 99(19):1462-1470
4. American College of Medicine Genetics. Board of Directors (2004) Acmg statement on direct-to-consumer genetic testing. Genet Med 6(1):60
5. Atkin W (2003) Options for screening for colorectal cancer. Scand J Gastroenterol Suppl 237:13-16
6. Autier P, Boyle P, Buyse M, Bleiberg H (2003) Is FOB screening really the answer for lowering mortality in colorectal cancer? Recent Results Cancer Res 163:254-263, (discussion 264-266)
7. Bampton PA, Young GP, John JS (2000) Screening for colorectal cancer will save lives. Med J Aust 172(12):576-577
8. Broderick P, Carvajal-Carmona L, Pittman AM, Webb E, Howarth K, Rowan A, Lubbe S, Spain S, Sullivan K, Fielding S, Jaeger E, Vijayakrishnan J, Kemp Z, Gorman M, Chandler I, Papaemmanuil E, Penegar S, Wood W, Sellick G, Qureshi M, Teixeira A, Domingo E, Barclay E, Martin L, Sieber O, Consortium C, Kerr D, Gray R, Peto J, Cazier JB, Tomlinson I, Houlston RS (2007) A genome-wide association study shows that common alleles of smad7 influence colorectal cancer risk. Nat Genet 39(11):1315-1317
9. Browning S, Browning B (2007) Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet 81(5):1084-1097
10. Campbell H, Hawken S, Theodoratou E, Demarsh A, Hutchings K, Johnson CY, Masson L, Sharp L, Tait V, Little J (2009) Cumulative assessment of the role of human genome variation in colorectal cancer. In: Human genome epidemiology, 2nd edn. Oxford University Press, Oxford
11. Canadian Cancer Society Steering Committee (2009) Canadian cancer statistics 2009. http://www.cancer.ca/canada-wide/aboutcancer/cancerstatistics/ canadiancancerstatistics.aspx
12. Caulfield T, Burgess M, Williams-Jones B (2001) Providing genetic testing through the private sector: a view from Canada. Can J Policy Res 2(3):72-81
13. Chapelle ADL (2004) Genetic predisposition to colorectal cancer. Nat Rev Cancer 4(10):769-780
14. Chen K, Jiang QT, He HQ (2005) Relationship between metabolic enzyme polymorphism and colorectal cancer. World J Gastroenterol 11(3):331-335
15. De Jong MM, Nolte IM, te Meerman GJ, van der Graaf WTA, De Vries EGE, Sijmons RH, Hofstra RMW, Kleibeuker JH (2002) Low-penetrance genes and their involvement in colorectal cancer susceptibility. Cancer Epidemiol Biomarkers Prev 11(11):1332-1352
16. Gertig DM, Stampfer M, Haiman C, Hennekens CH, Kelsey K, Hunter DJ (1998) Glutathione s-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev 7(11):1001-1005
17. Goldstein D (2009) Common genetic variation and human traits. N Engl J Med 360(17):1696-1698
18. Gollust SE, Wilfond BS, Hull SC (2003) Direct-to-consumer sales of genetic services on the internet. Genet Med 5(4):332-337
19. Gray S, Olopade OI (2003) Direct-to-consumer marketing of genetic tests for cancer: buyer beware. J Clin Oncol 21(17): 3191-3193
20. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143(1):29-36
21. Harrell FE, Califf RM, Pryor DB, Lee KL, Rosati RA (1982) Evaluating the yield of medical tests. JAMA 247(18):2543-2546
22. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E (2007) Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Syst Rev 1:CD001,216 (online)
23. Houlston RS, Tomlinson IP (2001) Polymorphisms and colorectal tumor risk. Gastroenterology 121(2):282-301
24. Houlston RS, Webb E, Broderick P, Pittman AM, Bernardo MCD, Lubbe S, Chandler I, Vijayakrishnan J, Sullivan K, Penegar S, Carvajal-Carmona L, Howarth K, Jaeger E, Spain SL, Walther A, Barclay E, Martin L, Gorman M, Domingo E, Teixeira AS, Kerr D, Cazier JB, Niittymäki I, Tuupanen S, Karhu A, Aaltonen LA, Tomlinson IPM, Farrington SM, Tenesa A, Prendergast JGD, Barnetson RA, Cetnarskyj R, Porteous ME, Pharoah PDP, Koessler T, Hampe J, Buch S, Schafmayer C, Tepel J, Schreiber S, Völzke H, Chang-Claude J, Hoffmeister M, Brenner H, Zanke BW, Montpetit A, Hudson TJ, Gallinger S, Campbell H, Dunlop MG (2008) Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet 40(12):1426-1435
25. Human Genetics Commission UK (2003) Genes direct: ensuring the effective oversight of genetic tests directly to the public. http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH4084423
26. Jaeger E, Webb E, Howarth K, Carvajal-Carmona L, Rowan A, Broderick P, Walther A, Spain S, Pittman A, Kemp Z, Sullivan K, Heinimann K, Lubbe S, Domingo E, Barclay E, Martin L, Gorman M, Chandler I, Vijayakrishnan J, Wood W, Papaemmanuil E, Penegar S, Qureshi M, Consortium C, Farrington S, Tenesa A, Cazier JB, Kerr D, Gray R, Peto J, Dunlop M, Campbell H, Thomas H, Houlston R, Tomlinson I (2008) Common genetic variants at the crac1 (hmps) locus on chromosome 15q13.3 influence colorectal cancer risk. Nat Genet 40(1):26-28
27. Janssens ACJW, Pardo MC, Steyerberg EW, Duijn CMV (2004) Revisiting the clinical validity of multiplex genetic testing in complex diseases. Am J Hum Genet 74(3):585-588. author reply 588-589
28. Janssens ACJW, Moonesinghe R, Yang Q, Steyerberg EW, Duijn CMV, Khoury MJ (2007) The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases. Genet Med 9(8):528-535
29. Janssens ACJW, Gwinn M, Bradley LA, Oostra BA, Duijn CMV, Khoury MJ (2008) A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet 82(3):593-599
30. Kemp Z, Thirlwell C, Sieber O, Silver A, Tomlinson I (2004) An update on the genetics of colorectal cancer. Hum Mol Genet 13(2):R177-R185
31. Khoury MJ, Yang Q, Gwinn M, Little J, Flanders WD (2004) An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions. Genet Med 6(1):38-47
32. Kronborg O, Jørgensen OD, Fenger C, Rasmussen M (2004) Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol 39(9):846-851
33. Küry S, Buecher B, du Pont SR, Scoul C, Colman H, Neel TL, Houérou CL, Faroux R, Ollivry J, Lafraise B, Chupin LD, Sébille V, Bézieau S (2008) Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study. BMC Cancer 8:326
34. Kutz G (2006) Nutrigenetic testing: tests purchased from four web sites mislead consumers: testimony before the special committee on aging, US senate. http://purl.access.gpo.gov/GPO/LPS73075
35. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer\analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343(2):78-85
36. Ling BS, Moskowitz MA, Wachs D, Pearson B, Schroy PC (2001) Attitudes toward colorectal cancer screening tests. J Gen Intern Med 16(12):822-830
37. Little J, Sharp L (2007) Colorectal cancer. In: Epidemiology of colorectal cancer. Informa Healthcare, New York, pp 43-75
38. Madlensky L, Esplen MJ, Gallinger S, McLaughlin JR, Goel V (2003) Relatives of colorectal cancer patients: factors associated with screening behavior. Am J Prev Med 25(3):187-194
39. Madlensky L, McLaughlin JR, Carroll JC, Goel V, Frank JW (2005) Risks and benefits of population-based genetic testing for Mendelian subsets of common diseases were examined using the example of colorectal cancer risk. J Clin Epidemiol 58(9):934-941
40. Mandelson MT, Curry SJ, Anderson LA, Nadel MR, Lee NC, Rutter CM, LaCroix AZ (2000) Colorectal cancer screening participation by older women. Am J Prev Med 19(3):149-154
41. McCabe LL, McCabe ERB (2004) Direct-to-consumer genetic testing: access and marketing. Genet Med 6(1):60
42. Moayyedi P, Achkar E (2006) Does fecal occult blood testing really reduce mortality? A reanalysis of systematic review data. Am J Gastroenterol 101(2):380-384
43. Müller AD, Sonnenberg A (1995) Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 155(16):1741-1748
44. Multicentre Australian Colorectal-neoplasia Screening (MACS) Group (2006) A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. Med J Aust 184(11):546-550
45. National Committee on Colorectal Cancer Screening (2002) Recommendations for population-based colorectal cancer screening. http://www.phac-aspc.gc.ca/ publicat/ncccs-cndcc/techrep-eng.php
46. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM (1992) Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84(20):1572-1575
47. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31(1):33-36
48. Pharoah PDP, Antoniou AC, Easton DF, Ponder BAJ (2008) Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 358(26):2796-2803
49. Rabeneck L, Paszat LF (2004) A population-based estimate of the extent of colorectal cancer screening in Ontario. Am J Gastroenterol 99(6):1141-1144
50. Ramji F, Cotterchio M, Manno M, Rabeneck L, Gallinger S (2005) Association between subject factors and colorectal cancer screening participation in Ontario, Canada. Cancer Detect Prev 29(3):221-226
51. Ransohoff DF (2002) Lessons from the UK sigmoidoscopy screening trial. Lancet 359(9314):1266-1267
52. Rex DK, Rahmani EY, Haseman JH, Lemmel GT, Kaster S, Buckley JS (1997) Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 112(1):17-23
53. Schabas RE (2003) Colorectal cancer screening in Canada: it's time to act. Can Med Assoc J 68(2):178-179
54. Selby JV, Friedman GD, Quesenberry CP, Weiss NS (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326(10):653-657
55. Sharp L, Little J (2004) Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a huge review. Am J Epidemiol 159(5):423-443
56. Simon JB (2000) Screening colonoscopy: is it time? Can Med Assoc J 163(10):1277-1278
57. Sirovich BE, Schwartz LM, Woloshin S (2003) Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA 289(11):1414-1420
58. Slattery ML, Edwards SL, Ma KN, Friedman GD (2000) Colon cancer screening, lifestyle, and risk of colon cancer. Cancer Causes Control 11(6):555-563
59. Slattery ML, Kinney AY, Levin TR (2004) Factors associated with colorectal cancer screening in a population-based study: the impact of gender, health care source, and time. Prev Med 38(3):276-283
60. Statistics Canada (2006) Age and sex distribution of the Canadian population http://www12.statcan.gc.ca/english/census06/data/topics/Index.cfm, Statistics Canada
61. Tenesa A, Farrington SM, Prendergast JG, Porteous ME, Walker M, Haq N, Barnetson RA, Theodoratou E, Cetnarskyj R, Cartwright N, Semple C, Clark AJ, Reid FJ, Smith LA, Kavoussanakis K, Koessler T, Pharoah PD, Buch S, Schafmayer C, Tepel J, Schreiber S, Volzke H, Schmidt CO, Hampe J, Chang-Claude J, Hoffmeister M, Brenner H, Wilkening S, Canzian F, Capella G, Moreno V, Deary IJ, Starr JM, Tomlinson IP, Kemp Z, Howarth K, Carvajal-Carmona L, Webb E, Broderick P, Vijayakrishnan J, Houlston RS, Rennert G, Ballinger D, Rozek L, Gruber SB, Matsuda K, Kidokoro T, Nakamura Y, Zanke BW, Greenwood CM, Rangrej J, Kustra R, Montpetit A, Hudson TJ, Gallinger S, Campbell H, Dunlop MG (2008) Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet 40(5):631-637
62. Thomas DC (2004) Statistical methods in genetic epidemiology. Oxford University Press, New York
63. Tomlinson I, Webb E, Carvajal-Carmona L, Broderick P, Kemp Z, Spain S, Penegar S, Chandler I, Gorman M, Wood W, Barclay E, Lubbe S, Martin L, Sellick G, Jaeger E, Hubner R, Wild R, Rowan A, Fielding S, Howarth K, Corgi C, Silver A, Atkin W, Muir K, Logan R, Kerr D, Johnstone E, Sieber O, Gray R, Thomas H, Peto J, Cazier JB, Houlston R (2007) A genome-wide association scan of tag snps identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 39(8):984-988
64. Tomlinson IPM, Webb E, Carvajal-Carmona L, Broderick P, Howarth K, Pittman AM, Spain S, Lubbe S, Walther A, Sullivan K, Jaeger E, Fielding S, Rowan A, Vijayakrishnan J, Domingo E, Chandler I, Kemp Z, Qureshi M, Farrington SM, Tenesa A, Prendergast JGD, Barnetson RA, Penegar S, Barclay E, Wood W, Martin L, Gorman M, Thomas H, Peto J, Bishop DT, Gray R, Maher ER, Lucassen A, Kerr D, Evans DGR, Consortium C, Schafmayer C, Buch S, Völzke H, Hampe J, Schreiber S, John U, Koessler T, Pharoah P, van Wezel T, Morreau H, Wijnen JT, Hopper JL, Southey MC, Giles GG, Severi G, Castellví-Bel S, Ruiz-Ponte C, Carracedo A, Castells A, Consortium E, Försti A, Hemminki K, Vodicka P, Naccarati A, Lipton L, Ho JWC, Cheng KK, Sham PC, Luk J, Agúndez JAG, Ladero JM, De La Hoya M, Caldés T, Niittymäki I, Tuupanen S, Karhu A, Aaltonen L, Cazier JB, Campbell H, Dunlop MG, Houlston RS (2008) A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet 40(5):623-630
65. UK Flexible Sigmoidoscopy Screening Trial Investigators (2002) Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 359(9314):1291-1300
66. UK Trial of Early Detection of Breast Cancer Group (1988) First results on mortality reduction in the UK trial of early detection of breast cancer. Lancet 2(8608):411-416
67. Vineis P, Schulte P, McMichael AJ (2001) Misconceptions about the use of genetic tests in populations. Lancet 357(9257):709-712
68. Williams-Jones B (2003) Where there's a web, there's a way: commercial genetic testing and the internet. Community genetics 6(1):46-57
69. Yang Q, Khoury MJ, Botto L, Friedman JM, Flanders WD (2003) Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am J Hum Genet 72(3):636-649
70. Yang Q, Khoury MJ, Friedman J, Little J, Flanders WD (2005) How many genes underlie the occurrence of common complex diseases in the population? Int J Epidemiol 34(5):1129-1137
71. Zanke BW, Greenwood CM, Rangrej J, Kustra R, Tenesa A, Farrington SM, Prendergast J, Olschwang S, Chiang T, Crowdy E, Ferretti V, Laflamme P, Sundararajan S, Roumy S, Olivier JF, Robidoux F, Sladek R, Montpetit A, Campbell P, Bezieau S, O'Shea AM, Zogopoulos G, Cotterchio M, Newcomb P, McLaughlin J, Younghusband B, Green R, Green J, Porteous ME, Campbell H, Blanche H, Sahbatou M, Tubacher E, Bonaiti-Pellie C, Buecher B, Riboli E, Kury S, Chanock SJ, Potter J, Thomas G, Gallinger S, Hudson TJ, Dunlop MG (2007) Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 39:989-994